Felbamate Tablet
FDA Label NDC 70771-1077

1 label section · Submitted to the FDA by Zydus Lifesciences Limited · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Felbamate (NDC 70771-1077). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

NDC 70771-1077-1

Felbamate tablets USP, 400 mg

100 Tablets

Rx only

400 mg (785f1747 E29d 432a 82e7 Fcaeea202327 01)

400 mg (785f1747 E29d 432a 82e7 Fcaeea202327 01)

NDC 70771-1078-1

Felbamate tablets USP, 600 mg

100 Tablets

Rx only

600 mg (785f1747 E29d 432a 82e7 Fcaeea202327 02)

600 mg (785f1747 E29d 432a 82e7 Fcaeea202327 02)

* Please review the disclaimer below.